Kotak Global Innovation Overseas Equity Omni FoF Direct - Growth
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, International, Principal at very high risk
1 Year Return 21.51% at 23 Dec 2025 09:47 AM
Fund Details
NAV 13.1876
Sub-Type International
Rating Not Rated
Min. SIP Amount ₹100.0
Fund Age(Year) 4.4
Fund Size(in Crores) 557.28
Fund Performance
1 Month 4.22%
3 Month 4.52%
6 Month 19.9%
1 Year 21.51%
3 Year 25.02%
5 Year 0.0%
Know This Fund
As on 23 Dec 2025
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (100%) Market Cap Mid Cap 36.81 Small Cap 28.41 Large Cap 34.78 Top Sectors Healthcare 99.52 Services 0.28 Chemicals 0.2 Top Holding Sigachi Industries 0.05 Pfizer 0.55 Lincoln Pharma 0.04 Natco Pharma 0.57 KMC Speciality Hospitals (India) 0.02 Sastasundar Ventures 0.02 Windlas Biotech 0.05 Unichem Laboratories 0.07 Cohance Lifesciences 0.52 SMS Pharmaceuticals 0.07 Metropolis Healthcare 0.37 Anuh Pharma 0.02 Gufic Biosciences 0.07 Sai Life Sciences 0.65 Aarti Pharmalabs 0.26 Jubilant Pharmova 0.65 Glaxosmithkline Pharma 0.76 Shalby 0.04 Ajanta Pharma 0.79 Thyrocare Technologies 0.17 Krsnaa Diagnostics 0.11 Syncom Formulations (India) 0.05 Alkem Laboratories 2.33 Strides Pharma Science 0.42 Fermenta Biotech 0.02 Artemis Medicare Services 0.06 Senores Pharmaceuticals 0.16 Shree Ganesh Remedies 0.01 Concord Biotech 0.35 Morepen Laboratories 0.11 Indoco Remedies 0.07 Novartis India 0.04 Alivus Life Sciences 0.2 Kovai Medical Center & Hospital 0.2 Torrent Pharmaceuticals 2.85 Onesource Specialty Pharma 0.6 Bliss GVS Pharma 0.08 3B BlackBio Dx 0.05 Innova Captab 0.08 Narayana Hrudayalaya 0.96 Apollo Hospitals Enterprise 5.38 Nectar Lifesciences 0.02 Mankind Pharma 1.83 Hester Biosciences 0.05 Aurobindo Pharma 2.49 Healthcare Global Enterprises 0.27 Poly Medicure 0.55 Aster DM Healthcare 1.08 Biocon 1.75 Astrazeneca Pharma India 0.41 Sun Pharmaceutical Industries 14.1 Tarsons Products 0.03 Laxmi Dental 0.03 Jupiter Life Line Hospitals 0.4 Rainbow Children's 0.49 Lupin 3.67 Emcure Pharmaceuticals 0.25 Zydus Lifesciences 1.73 Solara Active Pharma Sciences 0.11 Orchid Pharma 0.09 Advanced Enzyme Technologies 0.11 Sanofi Consumer Healthcare India 0.23 Sanofi India 0.29 Wockhardt 0.75 Max Healthcare Institute 6.27 Sequent Scientific 0.19 Vijaya Diagnostic Centre 0.35 FDC 0.15 Caplin Point Laboratories 0.28 Blue Jet Healthcare 0.1 Jagsonpal Pharmaceuticals 0.03 Sun Pharma Adv Resrc 0.09 Aarti Drugs 0.11 Abbott India 1.11 Akums Drugs And Pharmaceuticals 0.08 Gland Pharma 1.02 Panacea Biotec 0.04 Dr. Agarwal's Health Care 0.3 Themis Medicare 0.02 Procter & Gamble Health 0.33 Dr. Reddy's Laboratories 5.59 Glenmark Pharmaceuticals 2.12 Suven Life Sciences 0.07 Supriya Lifescience 0.14 Marksans Pharma 0.29 Kwality Pharmaceuticals 0.03 Dishman Carbogen Amcis 0.11 Fischer Medical Ventures 0.04 IOL Chemicals 0.08 Alembic Pharmaceuticals 0.36 Suraksha Diagnostic 0.04 Divi's Laboratories 6.02 Fortis Healthcare 3.49 Bajaj Healthcare 0.03 Kopran 0.03 RPG Life Sciences 0.07 Cipla 6.22 GPT Healthcare 0.03 JB Chemicals 1.05 Indraprastha Medical Corporation 0.16 Laurus Labs 2.92 Eris Lifesciences 0.48 Syngene International 0.9 Piramal Pharma 0.84 Krishna Institute 1.22 Dr Agarwals Eye Hospital 0.05 Acutaas Chemicals 0.69 Dr. Lal Pathlabs 0.84 Yatharth Hospital & Trauma Care Services 0.19 Indegene 0.39 Hikal 0.06 Ipca Laboratories 1.48 Granules India 0.59 Global Health 0.76 Shilpa Medicare 0.27 Wanbury 0.04 Gujarat Themis 0.09 Vimta Labs 0.07 Neuland Laboratories 1.08
Debt & Others (0%) Sector Allocation Net Payables -0.44 Reverse Repo 0.44 Margin Money 0 Debt Credit Ratings Debt Category Others 0.0
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -0.35% Ret 1Y -1.05% Ret 3Y 20.7% Ret 5Y 14.07%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -0.35% Ret 1Y -1.05% Ret 3Y 20.7% Ret 5Y 14.07%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.35% Ret 1Y -1.05% Ret 3Y 20.7% Ret 5Y 14.07%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.6% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.6% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.6% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -0.39% Ret 1Y -0.12% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -1.16% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0.49%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Arjun Khanna
Education Mr. Khanna has done CFA, FRM, MMS(Finance) & B.E (Electronics)
Experience Prior to joining Kotak Mahindra Mutual Fund, he was with Principal Mutual Fund and has also worked with Citibank.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 42
Date of Incorporation 2021-07-29
Total AUM 2025-11-30
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.